Ikeda Yuki, Nasu Mizuho
Microbiology, Innovation Labo Research Center, Tokyo, JPN.
Pharmacology, Innovation Labo Research Center, Tokyo, JPN.
Cureus. 2022 Feb 28;14(2):e22714. doi: 10.7759/cureus.22714. eCollection 2022 Feb.
Upper airway problems and stress can cause sleep disorders. The present study was designed to evaluate the efficacy and safety of wild sage metabolites (WSM) for snoring treatment and alpha wave activation in healthy men and women. A total of 42 subjects compliant with inclusion criteria were randomly assigned to one of the two groups, viz. Group 1-WSM and Group 2-Placebo, using a simple randomization process. Consumption of WSM by healthy men and women resulted in the decrease of Pittsburgh Sleep Quality Index (PSQI) global score by 29%, improved assessment by their sleep mates, and increased alpha brain wave by 55%. In conclusion, medication with WSM resulted in significant reduced snoring, stress, and improved sleep quality after 30 days, with a good tolerance among subjects. No side effects or adverse events were reported during the study. Hence, WSM at 450 mg/day could be recommended as an effective agent for snoring treatment, improving the quality of sleep, and stress reduction.
上呼吸道问题和压力会导致睡眠障碍。本研究旨在评估野生鼠尾草代谢产物(WSM)对健康男性和女性打鼾治疗及α波激活的有效性和安全性。采用简单随机化方法,将42名符合纳入标准的受试者随机分为两组,即第1组-WSM组和第2组-安慰剂组。健康男性和女性服用WSM后,匹兹堡睡眠质量指数(PSQI)全球评分降低了29%,睡眠伙伴的评估得到改善,α脑波增加了55%。总之,服用WSM 30天后,打鼾、压力显著减轻,睡眠质量得到改善,受试者耐受性良好。研究期间未报告副作用或不良事件。因此,建议每天服用450毫克WSM作为治疗打鼾、改善睡眠质量和减轻压力的有效药物。